塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2011/04/14 | 1,399 | 1,403 | 1,380 | 1,389 | -27 | -1.9% | 1,389,200 |
2011/04/13 | 1,414 | 1,429 | 1,410 | 1,416 | +1 | +0.1% | 1,270,400 |
2011/04/12 | 1,428 | 1,432 | 1,409 | 1,415 | -36 | -2.5% | 951,500 |
2011/04/11 | 1,430 | 1,455 | 1,422 | 1,451 | +16 | +1.1% | 1,134,400 |
2011/04/08 | 1,414 | 1,445 | 1,399 | 1,435 | +25 | +1.8% | 1,700,800 |
2011/04/07 | 1,418 | 1,419 | 1,403 | 1,410 | ±0 | ±0% | 877,800 |
2011/04/06 | 1,435 | 1,443 | 1,410 | 1,410 | +10 | +0.7% | 1,710,000 |
2011/04/05 | 1,417 | 1,437 | 1,391 | 1,400 | +4 | +0.3% | 1,901,400 |
2011/04/04 | 1,408 | 1,417 | 1,396 | 1,396 | -6 | -0.4% | 659,700 |
2011/04/01 | 1,412 | 1,429 | 1,401 | 1,402 | -17 | -1.2% | 1,069,200 |
2011/03/31 | 1,401 | 1,422 | 1,393 | 1,419 | +22 | +1.6% | 1,264,500 |
2011/03/30 | 1,373 | 1,397 | 1,365 | 1,397 | +24 | +1.7% | 1,038,300 |
2011/03/29 | 1,358 | 1,379 | 1,352 | 1,373 | -4 | -0.3% | 1,478,600 |
2011/03/28 | 1,392 | 1,395 | 1,366 | 1,377 | -7 | -0.5% | 865,800 |
2011/03/25 | 1,372 | 1,386 | 1,369 | 1,384 | +22 | +1.6% | 907,700 |
2011/03/24 | 1,379 | 1,380 | 1,356 | 1,362 | -10 | -0.7% | 1,194,800 |
2011/03/23 | 1,394 | 1,420 | 1,365 | 1,372 | -20 | -1.4% | 1,903,900 |
2011/03/22 | 1,380 | 1,400 | 1,365 | 1,392 | +62 | +4.7% | 2,412,800 |
2011/03/18 | 1,355 | 1,379 | 1,316 | 1,330 | -25 | -1.8% | 2,495,400 |
2011/03/17 | 1,270 | 1,369 | 1,244 | 1,355 | +82 | +6.4% | 3,960,800 |
2011/03/16 | 1,245 | 1,295 | 1,236 | 1,273 | +58 | +4.8% | 3,570,800 |
2011/03/15 | 1,370 | 1,392 | 1,157 | 1,215 | -213 | -14.9% | 3,375,000 |
2011/03/14 | 1,452 | 1,498 | 1,424 | 1,428 | -74 | -4.9% | 1,429,500 |
2011/03/11 | 1,510 | 1,532 | 1,502 | 1,502 | -28 | -1.8% | 4,070,500 |
2011/03/10 | 1,530 | 1,541 | 1,525 | 1,530 | -5 | -0.3% | 1,040,300 |
2011/03/09 | 1,539 | 1,543 | 1,532 | 1,535 | +12 | +0.8% | 573,700 |
2011/03/08 | 1,521 | 1,532 | 1,521 | 1,523 | ±0 | ±0% | 700,300 |
2011/03/07 | 1,550 | 1,550 | 1,522 | 1,523 | -33 | -2.1% | 879,800 |
2011/03/04 | 1,565 | 1,570 | 1,554 | 1,556 | +13 | +0.8% | 748,300 |
2011/03/03 | 1,540 | 1,550 | 1,532 | 1,543 | +3 | +0.2% | 714,000 |
2011/03/02 | 1,556 | 1,580 | 1,535 | 1,540 | -34 | -2.2% | 1,103,500 |
2011/03/01 | 1,588 | 1,588 | 1,569 | 1,574 | +25 | +1.6% | 1,168,800 |
2011/02/28 | 1,537 | 1,554 | 1,524 | 1,549 | +12 | +0.8% | 877,600 |
2011/02/25 | 1,549 | 1,554 | 1,535 | 1,537 | -4 | -0.3% | 992,300 |
2011/02/24 | 1,563 | 1,580 | 1,540 | 1,541 | -28 | -1.8% | 1,416,800 |
2011/02/23 | 1,594 | 1,602 | 1,569 | 1,569 | -20 | -1.3% | 944,100 |
2011/02/22 | 1,588 | 1,605 | 1,587 | 1,589 | -11 | -0.7% | 1,210,700 |
2011/02/21 | 1,610 | 1,613 | 1,590 | 1,600 | -32 | -2% | 1,301,800 |
2011/02/18 | 1,595 | 1,640 | 1,591 | 1,632 | +39 | +2.4% | 2,347,700 |
2011/02/17 | 1,572 | 1,596 | 1,570 | 1,593 | +21 | +1.3% | 1,183,800 |
2011/02/16 | 1,569 | 1,575 | 1,559 | 1,572 | -5 | -0.3% | 810,600 |
2011/02/15 | 1,579 | 1,580 | 1,568 | 1,577 | +4 | +0.3% | 558,500 |
2011/02/14 | 1,566 | 1,576 | 1,558 | 1,573 | -3 | -0.2% | 658,000 |
2011/02/10 | 1,555 | 1,580 | 1,555 | 1,576 | +17 | +1.1% | 1,001,400 |
2011/02/09 | 1,557 | 1,562 | 1,552 | 1,559 | +6 | +0.4% | 787,300 |
2011/02/08 | 1,552 | 1,557 | 1,545 | 1,553 | +2 | +0.1% | 724,200 |
2011/02/07 | 1,564 | 1,566 | 1,547 | 1,551 | +3 | +0.2% | 1,088,700 |
2011/02/04 | 1,529 | 1,553 | 1,529 | 1,548 | +29 | +1.9% | 1,014,800 |
2011/02/03 | 1,514 | 1,524 | 1,508 | 1,519 | -10 | -0.7% | 819,800 |
2011/02/02 | 1,532 | 1,536 | 1,523 | 1,529 | -11 | -0.7% | 964,100 |
3451~
3500
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 233,900円 | +20.9% | +10.6% | 2.82% | 11.06倍 | 1.46倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 665,000円 | +2.2% | +10.2% | 1.80% | 12.77倍 | 1.28倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 139,300円 | +0.9% | +380.2% | 5.60% | 19.18倍 | 1.65倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
協和キリン | 220,200円 | -3.5% | -11.3% | 2.72% | 20.23倍 | 1.36倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
エーザイ | 387,800円 | +0.1% | -3.4% | 4.13% | 26.36倍 | 1.30倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム